| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.0049 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |